Stock exchanges & markets

Overview Watchlists

Clariant Q3 EBITDA before exceptional items falls 7% to CHF 151.5 million

(AWP Alliance News) - Clariant's third-quarter 2026 EBITDA before exceptional items fell 7% year over year to CHF 151.5 million. The decline reflected normalized Corporate costs, lower operating leverage in Catalysts, and unfavorable mix and raw-material effects in Care Chemicals and Catalysts.

Sales rose 7% to CHF 968.8 million. Clariant maintained its 2026 outlook for an EBITDA margin before exceptional items of around 18%, supported by a strong fourth-quarter order book, particularly in Catalysts, and performance improvement programs.

https://docs.publicnow.com/0A06868BBACA701C338F36830ECA07575DD24DB6

Disclaimer: This news brief was created using generative artificial intelligence. Clariant AG published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now